$KMB

Barclays Adjusts Price Target on Kimberly-Clark to $105 From $115, Keeps Equalweight Rating

Barclays lowered its price target on Kimberly-Clark (KMB) from $115 to $105, maintaining an equalweight rating. The company is reportedly considering asset sales to secure EU approval for its Kenvue acquisition. KMB's stock price was $98.15 at the time of the report.

Original reporting
Published Sep 14, 2026, 10:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 1:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$KMB
Bearish
medium confidence
Mentioned
$KMB
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$KMBBearishMed
01

Why it matters

The downgrade signals a bearish stance, prompting traders to reconsider exposure.

02

Market read

Analyst target cuts can influence short‑term price action and sector sentiment.

03

What to watch

Potential upside from upcoming product launches and international market expansion.

Relevance 7/10Novelty 7/10Timing: pre-market

Background

Barclays updated its valuation model for Kimberly-Clark, resulting in a lower price target.

Company-level read

Ticker impact

$KMBBearishMedium confidence
Context

Barclays lowered Kimberly-Clark price target to $105 from $115.

Expected impact

Potential short‑term downside pressure on KMB.

Evidence & confidence

Target reduction reflects weaker outlook; traders may trim long positions.

Market effects

Consumer staples may see modest valuation adjustments as analysts reassess pricing.

U.S. market sentiment could dip slightly in the consumer staples segment.

Limited; primarily affects U.S. investors focused on Kimberly-Clark.

Counterpoint

The target cut may be overly pessimistic if recent cost‑saving initiatives materialize.

Key entities

  • Kimberly-Clark

    U.S. consumer staples company (ticker KMB).

  • Barclays

    Investment bank providing the price target revision.

Related articles

$KMBHighAI 9/10

Exclusive-Kimberly-Clark readies asset sales in bid for EU nod for Kenvue deal, sources say

Kimberly-Clark (KMB) is preparing asset sales to address EU antitrust concerns regarding its $40 billion acquisition of Kenvue. The EU is expected to formally raise its concerns this week, with Kimberly-Clark facing a September 29 deadline to submit concessions or face a full investigation. The deal has already received conditional approval in Australia and South Africa.

$KMBHighAI 9/10

Kimberly-Clark’s 54-Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal

Kimberly-Clark (KMB) extended its 54-year dividend increase streak to $5.12 annualized while finalizing a $48.7 billion acquisition of Kenvue (KVUE). Operating cash flow of $2.8 billion covers dividends and capex, but leaves little room before Kenvue financing impacts its balance sheet. KMB shares have fallen 20% to $98 over the past year, pushing the yield to 5%.

$KMBMedAI 9/10

Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal

Kimberly-Clark (KMB) extended its 54-year dividend increase streak to $5.12 annualized while closing a $48.7 billion Kenvue (KVUE) acquisition, raising concerns about its balance sheet. Operating cash flow of $2.8 billion covers dividends and capex, but leaves little cushion. KMB shares fell 20% to $98, pushing the yield to 5%. The company's dividend streak and acquisition are under scrutiny as investors assess the financial impact.

$KMBMedAI 8/10

Wells Fargo cuts Kimberly-Clark stock price target on earnings concerns

Wells Fargo reduced its price target for Kimberly-Clark (NYSE:KMB) to $105 from $110, citing earnings uncertainty due to competition and China headwinds. The stock is down 7.5% over the past week. Despite challenges, some analysts see the stock as undervalued. Q2 earnings beat estimates but revenue missed expectations. Other analysts upgraded KMB's rating, citing potential earnings boosts from acquisitions.